Study on the effect of clinical pharmacists participating in anti-infection treatment for severe infection patients in the intensive care unit
10.12173/j.issn.1005-0698.202405021
- VernacularTitle:临床药师参与重症监护室重症感染患者抗感染治疗效果研究
- Author:
Xinyue ZHANG
1
;
Zhi LI
;
Ping YANG
;
Min SUN
;
Chuanwei YANG
Author Information
1. 济南市第四人民医院药学部(济南 250031)
- Keywords:
Clinical pharmacist;
ICU;
Severe infection;
Pharmaceutical care;
Treatment effect
- From:
Chinese Journal of Pharmacoepidemiology
2024;33(8):877-883
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effectiveness of clinical pharmacists participating in anti-infection treatment for severe infection patients in the intensive care unit.Methods A retrospective collection of severe infection patients admitted to the ICU of the Fourth People's Hospital of Jinan from January to June 2023 was conducted through the hospital information system.Among them,some patients with clinical pharmacists participating in anti-infection treatment throughout the process were in the intervention group,and other patients who did not participate in treatment were in the control group.Both groups of patients received routine treatment according to clinical diagnosis.We compared the cure rate,incidence of adverse reactions,cost of antibiotics,proportion of antibiotic costs,pathogen testing rate,duration of antibiotic treatment,and average length of hospital stay between two groups of patients,and conducted statistical analysis.Results A total of 147 patients were included,with 66 in the intervention group and 81 in the control group.The cure rate of patients in the intervention group was 65.15％,significantly higher than 46.91％in the control group(P＜0.05);The incidence of adverse reactions(7.58％)was significantly lower than that of the control group(19.75％)(P＜0.05).The usage rates of quinolone drugs and tigecycline were significantly reduced in the intervention group;The intervention group had significantly better indicators such as antibiotic costs,proportion of antibiotic costs,and patient pathogen testing rate than the control group(P＜0.05).There were no significant difference in the duration of antimicrobial treatment and average length of hospital stay between the two groups(P＞0.05).Conclusion The full participation of clinical pharmacists in the anti-infection treatment of ICU severe infection patients can help improve their clinical cure rate and medication safety,and reduce their medical burden.
